Tai Industries (519483)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹42.5 |
| Market Cap | ₹25.7 Cr |
| P/E Ratio | 450 |
| ROCE | 6% |
| ROE | 0.14% |
| Dividend Yield | 0% |
| Profit Growth | -196.77% |
| Debt/Equity | — |
| Sales Growth | -39.64% |
| 52-Week Range | ₹20.7 — ₹42.5 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹50 |
Strengths
- Price of ₹42.50 is below book value of ₹50, giving a P/B of 0.85.
- Latest quarter sales of ₹40 Cr show the trading operations still have some activity.
- ROCE of 6% is low but positive, suggesting the business is not deeply loss-making at an operational level.
- Small market cap of ₹26 Cr can create pricing inefficiencies for a patient, focused investor.
Concerns
- Sales growth of -39.64% and profit growth of -196.77% signal a sharply shrinking business.
- ROE is just 0.14%, P/E is a meaningless 450, and dividend yield is 0%, so shareholders get no real return.
- Piotroski F-Score of 3/9 indicates weak financial health.
- Debt/Equity and promoter holding are N/A, leaving important questions about leverage and governance unanswered.
AI Analysis
Let me start with the obvious: at ₹42.50, Tai Industries sells below book value of ₹50, a P/B of 0.85. That is the only thing that brings me to the table. In Graham's language, buying at a discount to book gives a margin of safety, but only if the book is honest. With a Piotroski F-score of 3/9, I cannot trust the balance-sheet signals. The company is a trader and distributor; businesses like this rarely possess moats. The numbers confirm the struggle: sales growth has collapsed by 39.64%, profit growth has fallen by 196.77%, and ROE is a negligible 0.14%. The trailing P/E of 450 is meaningless when earnings are almost zero; the latest quarter still shows net profit rounded to -₹0 Cr on sales of ₹40 Cr, so the engine is not generating acceptable shareholder returns. ROCE of 6% is thin, and with no dividend, the minority shareholder gets no cash while waiting. I also notice debt/equity is not available, so I cannot evaluate leverage. The market cap is just ₹26 Cr, so this is a microcap; institutional scrutiny will be low. Am I being offered a dollar for 85 cents? Maybe, but a poor business at a low price is still a poor investment unless assets are realized or earnings recover. Graham would demand evidence: real net current assets, no hidden liabilities, and a credible path to profitability. I see none of that yet. For now, this is an asset play, not a compounding machine. I would wait for proof.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer